Skip to content
★ Sign in to follow
지엘

지엘팜텍 Stock: price and insider trades · South Korea

KR·Mcap ₩55.4BHealth Care

No insider purchase over the last 90 days. The latest, by 박상태, was filed 06 Aug 2026.

지엘팜텍: what insiders have been doing

Every trade that managers of 지엘팜텍 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 1 November 2026, 4 filings were filed, from 3 insiders.

Both sides are active: 1 purchase and 1 sale, from 1 insider and 1 insider respectively. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 senior executive.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 4 filings, this issuer sits below that mark. Since 2021, the database holds 6 purchases and 5 sales by insiders of the company.

The most recent open-market purchase was published on 6 August 2026, 95 days ago.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
29
Thresholds
n/a
Buy Volume
€179,312
6 ops. · all time
Sell Volume
€6M
5 ops. · all time

Who traded when

BuySale
더블유사이언스1 sale
박상태1 buy

Since the insiders bought

  • Filed 22 Mar 2023 · 1328 days ago · €11k
    +79.7%
    Entry ₩3,800 · Close at T+365 ₩6,830
  • Filed 16 Mar 2022 · 1699 days ago · €6,060
    -13.0%
    Entry ₩4,370 · Close at T+365 ₩3,800

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,744 of 26,913 companies
23.7
score / 100
Value
17
Quality
30
FCF yld-11%
Earn yld0.0%
EV/EBITDA41.8x
ROE-0.5%
Gross mgn41%
Net mgn0.0%
Debt/EBITDA11.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩3,570
Analyst consensus
·
Income statement
Revenue₩35.3B
Gross profit₩14.3B41% margin
EBITDA₩1.7B5% margin
Net income₩12.5M-0.3% margin
Valuation
Beta0.47
Balance sheet & cash
Market cap₩55.4B
Total debt₩18.7B
Free Cash Flow-₩5.5B
Debt / Equity105%
Profitability & ownership
ROE-0.5%
ROA0.3%
% insiders29.8%
% institutions0.0%
Last declaration on 6 August 2026
Declarations31 total
  • Other
    Other(filed)
    0DART
  • ▲
    생산본부장Executives(filed)
    €13kest.0DART
    5,171 sharesShareKRXDART:20260806000429
    Canonical exit: 4 Nov 2026 (T+90)
  • ▼
    10%이상주주Executives(filed)
    0DART
    18,470,933 sharesShareKRXDART:20260729000474
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    대량보유자Executives
    0DART
    3,470,376 sharesKRXDART:20240503000587
  • ▼
    Executives
    8B KRW10DART
    4,895,692 shares@ ₩1,603.1831100.0% of flowShareKRXDART:20240313001771
  • ▼
    대량보유자Executives
    0DART
    6,342,908 sharesKRXDART:20240313001703
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    0DART
    9,274,853 sharesKRXDART:20231204000346
    Canonical exit: 28 Feb 2024 (T+90)
  • ▲
    Executives
    0DART
    2,440,539 sharesKRXDART:20231201000239
    Canonical exit: 28 Feb 2024 (T+90)
  • ▼
    Executives
    €969kest.0DART
    269,372 sharesKRXDART:20231010000524
  • ▲
    Executives(filed)
    €150kest.0DART
    55,285 sharesKRXDART:20230322000488
    Canonical exit: 20 Jun 2023 (T+90)
  • ▲
    Executives
    15M KRW10DART
    19,499 shares@ ₩752.6658100.0% of flowShareKRXDART:20230322000429
    Canonical exit: 29 Mar 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    8M KRW10DART
    10,000 shares@ ₩820.00100.0% of flowShareKRXDART:20220316000038
    Canonical exit: 9 Jun 2022 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART

25 of 31 declarations

About 지엘팜텍

지엘팜텍 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations